Morgan Stanley Cuts IBM Price Objective 19% While UBS Upgrades to Neutral
Morgan Stanley lowered IBM’s price objective by 19% and maintained equal weight, citing AI disruption risks from a new Claude Code tool competing with mainframe stickiness. UBS upgraded its rating to neutral and set a target, while Roberts & Ryan scheduled a March 13 virtual session on quantum computing vulnerabilities.
1. Morgan Stanley Price Objective Cut
Morgan Stanley analyst Erik Woodring lowered IBM’s price objective to $247 from $304 and maintained an equal weight rating, highlighting AI disruption risks introduced by the new Claude Code tool relative to mainframe stickiness.
2. UBS Upgrades Rating to Neutral
UBS moved its recommendation from sell to neutral, setting a $236 target and pointing to recent volatility, balanced risk‐reward and potential catalysts such as software momentum, free cash flow upside and quantum developments.
3. Roberts & Ryan Quantum Computing Event
Roberts & Ryan will host a virtual session on March 13 at 12:30 pm ET examining quantum computing arrival, encryption vulnerabilities, global transaction security and broader geopolitical impacts, featuring senior defense and AI technology leaders.